- Home
- GSK vs SPGI Comparison
GSK vs SPGI Comparison
Compare GSK & SPGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GSK | SPGI |
|---|---|---|
| Founded | 1715 | 1860 |
| Country | United Kingdom | United States |
| Employees | 66841 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.7B | 124.6B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | GSK | SPGI |
|---|---|---|
| Price | $50.80 | $406.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 15 |
| Target Price | N/A | ★ $558.33 |
| AVG Volume (30 Days) | ★ 3.9M | 1.9M |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | ★ 3.40% | 0.90% |
| EPS Growth | N/A | ★ 18.70 |
| EPS | N/A | ★ 4.69 |
| Revenue | N/A | ★ $6,063,000,000.00 |
| Revenue This Year | $6.99 | $9.66 |
| Revenue Next Year | $4.19 | $7.35 |
| P/E Ratio | ★ $32.75 | $87.62 |
| Revenue Growth | N/A | ★ 7.10 |
| 52 Week Low | $35.45 | $381.61 |
| 52 Week High | $61.70 | $579.05 |
Technical Indicators
Market Signals| Indicator | GSK | SPGI |
|---|---|---|
| Relative Strength Index (RSI) | 45.51 | 41.86 |
| Support Level | $48.02 | $404.19 |
| Resistance Level | $51.79 | $436.46 |
| Average True Range (ATR) | 0.83 | 10.64 |
| MACD | 0.09 | -0.90 |
| Stochastic Oscillator | 46.93 | 6.44 |
Price Performance
Historical ComparisonAbout GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About SPGI S&P Global Inc.
S&P Global provides data and benchmarks to capital and commodity market participants. Its ratings business is the largest credit rating agency in the world and S&P's largest segment by profitability. S&P's largest segment by revenue is market intelligence, which provides desktop, data and advisory solutions, enterprise solutions, and credit/risk solutions mostly in the financial-services industry. S&P's other segments include energy (formerly commodity insights, this segment includes Platts and other data), mobility (Carfax), and indexes. S&P plans to spin off mobility in 2026.